Wealth Awesome
TSX open
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Trade ETFs with $0 commission

Buy and sell over 200 ETFs to build your portfolio, commission-free.¹

  • ✓Over 200 eligible ETFs, commission-free when you trade online
  • ✓Screeners and tools to find ETFs that fit your goals
  • ✓Any account type, backed by the CIBC Digital Banking Guarantee

¹Online trades in ETFs on the Eligible ETF List; hold at least one business day. ETF fund fees still apply. Conditions apply.

Stocks/TSX/LABS

Medipharm Labs Corp (LABS : TSX)

$0.07CAD+0.00 (%)Close of 2026-11-16

Common Stock

Follow LABS

LABS

Medipharm Labs Corp

Source:WealthAwesomeWealthAwesome
↓ $0.01 (-7.14%)
30 day period
$0.06$0.07$0.07Oct 5Oct 27Nov 16

Performance

1 Day

+0.00%

1 Week

+8.33%

1 Month

+0.00%

YTD

-7.14%

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Key Statistics

Market Cap

$27.77M

52W High

$0.10

52W Low

$0.06

P/E Ratio

-

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.84

Dividend Yield

-

Performance history

LABS returns since 2023

Medipharm Labs Corp has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −47.8% (Mar 2025 to Nov 2025).

1 year / yr

−7.1%

3 years / yr

0.0%

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2023*−7.1%
  • 2024−7.7%
  • 2025+8.3%
  • 2026*0.0%

* Partial year (first year of data, or year to date).

$10,000 invested in LABS

  • 1 year ago$9,286
  • 2023 (start of our data)$9,286
Best year
2025: +8.3%
Worst year
2024: −7.7%
All-time high in our data
$0 on Mar 24, 2025 · now −43.5%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.

Earnings

LABS earnings history

Medipharm Labs Corp beat the EPS estimate in 0 of its last 2 reported quarters.

-0.0100-0.00500.0000 24-0924-1225-0325-0625-0925-1226-0326-06 Estimate Actual (≥0) Actual (<0) Wealth Awesome
Quarter endingReportedEPSEstimateSurprise
Jun 30, 2026Aug 13, 2026$0.00——
Mar 31, 2026May 13, 2026−$0.00$0.00—
Dec 31, 2025Mar 30, 2026−$0.00$0.00—
Sep 30, 2025Nov 13, 2025−$0.01——
Jun 30, 2025Aug 14, 2025−$0.01——
Mar 31, 2025May 14, 2025−$0.00——
Dec 31, 2024Mar 31, 2025−$0.01——
Sep 30, 2024Nov 14, 2024−$0.01——

EPS as reported vs consensus estimate. TSX earnings calendar →

Awesome Portfolio™

Looking past LABS? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/16/2026$0.06$0.07$0.06$0.07$0.0716,735
11/13/2026$0.07$0.07$0.07$0.07$0.07115,659
11/12/2026$0.07$0.07$0.07$0.07$0.07238,344
11/11/2026$0.07$0.07$0.06$0.07$0.07715,784
11/10/2026$0.06$0.07$0.06$0.06$0.0669,490
11/9/2026$0.06$0.07$0.06$0.06$0.06290,446
11/6/2026$0.06$0.07$0.06$0.06$0.0680,370
11/5/2026$0.07$0.07$0.06$0.06$0.06350,743
11/4/2026$0.07$0.07$0.06$0.07$0.0764,831
11/3/2026$0.07$0.07$0.06$0.06$0.067,128

Analyst Price Targets

Based on analyst covering LABS · as of Sep 17, 2026

📈

Wall Street analysts forecast LABS stock price to rise 53.8% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.10

+53.8% Upside

Current Price

C$0.07

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on LABS's historical volatility

HistoricalForecast68%95%
C$0.02C$0.05C$0.08C$0.11C$0.14C$0.17TodayJul 9Sep 14Nov 16Dec 29Feb 11Mar 26

30-Day Vol

93.4%

Annualized

90-Day Vol

79.7%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.05

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.06C$0.04 – C$0.08
60 trading daysC$0.06C$0.04 – C$0.09
90 trading daysC$0.05C$0.03 – C$0.10

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Medipharm Labs Corp

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Financials

Revenue (TTM)
$41.46M
EBITDA
$-2.41M
Profit Margin
-12.00%
ROE (TTM)
-13.22%
EPS (Diluted)
-0.01
Book Value
0.08

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Tuesday Stock Pick

Tuesday morning

One Canadian stock and the case for it

  • The name with the biggest gap to analyst targets
  • The chart, insider buying and what is driving it
  • A plain-English bottom line, no hype

Free. One email a week. Unsubscribe any time.

Common Questions About LABS

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
HWOHigh Arctic Energy Services Inc.$1.74+29.85%
AAVAdvantage Oil & Gas Ltd.$13.45+23.74%
LUCLucara Diamond Corp$0.13+13.64%
TTelus Corp$13.70+12.85%
FRXFennec Pharmaceuticals Inc$18.35+10.81%
KELKelt Exploration Ltd.$12.72+10.70%
NVONovo Resources Corp$0.07+8.33%
ELOEloro Resources Ltd.$1.23+7.89%

Free with a Wealth Awesome account

Keep analysing LABS, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.